A long-term, post-treatment safety follow-up, multi-center study in patients with type 2 diabetes mellitus from the GALLANT, GALLEX or ARMOR studies

Trial Profile

A long-term, post-treatment safety follow-up, multi-center study in patients with type 2 diabetes mellitus from the GALLANT, GALLEX or ARMOR studies

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs Tesaglitazar (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms G-PLUS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 29 Nov 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 28 Aug 2006 Status change
    • 29 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top